Real-time enrollment status for this blast phase chronic myeloid leukemia, bcr-abl1 positive clinical trial
Current Status
Suspended
Checked: July 18, 2026 at 5:09 PM UTC
| NCT Number | NCT07166419 |
| Recruiting Status | Suspended |
| Condition | Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive |
| Phase | PHASE1 |
| Target Enrollment | 24 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Ohio State University Comprehensive Cancer Center |
| Last Updated on CT.gov | July 17, 2026 (Yesterday) |
As of July 18, 2026: Clinical trial NCT07166419 is currently suspended participants. This phase1 study for blast phase chronic myeloid leukemia, bcr-abl1 positive is not currently accepting new participants at 1 location across the United States. The study is sponsored by Ohio State University Comprehensive Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT07166419 is currently suspended. The study may resume recruiting in the future.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07166419 was last updated Yesterday (July 17, 2026). HelloStudys verifies this status automatically.